The global market for CRISPR Gene Testing and Diagnostics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC CRISPR Gene Testing and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States CRISPR Gene Testing and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe CRISPR Gene Testing and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China CRISPR Gene Testing and Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key CRISPR Gene Testing and Diagnostics players cover 10x Genomics, Aelian Biotechnology, Agilent Technologies, Axxam and Beckman Coulter, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global CRISPR Gene Testing and Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global CRISPR Gene Testing and Diagnostics market, with both quantitative and qualitative data, to help readers understand how the CRISPR Gene Testing and Diagnostics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the CRISPR Gene Testing and Diagnostics market and forecasts the market size by Type (Animals, Plants and Pathogens), by Application (Medical Industry, Agriculture and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Animals
Plants
Pathogens
Others
Segmentation by application
Medical Industry
Agriculture
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
10x Genomics
Aelian Biotechnology
Agilent Technologies
Axxam
Beckman Coulter
Becton, Dickinson and Company
Binx Health
bioM?rieux
Bio-Rad Laboratories
Caspr Biotech
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Roche
Sherlock Biosciences
Thermo Fisher Scientific
Vivlion
Chapter Introduction
Chapter 1: Scope of CRISPR Gene Testing and Diagnostics, Research Methodology, etc.
Chapter 2: Executive Summary, global CRISPR Gene Testing and Diagnostics market size and CAGR, CRISPR Gene Testing and Diagnostics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: CRISPR Gene Testing and Diagnostics revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global CRISPR Gene Testing and Diagnostics revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global CRISPR Gene Testing and Diagnostics market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including 10x Genomics, Aelian Biotechnology, Agilent Technologies, Axxam, Beckman Coulter, Becton, Dickinson and Company, Binx Health, bioM?rieux and Bio-Rad Laboratories, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CRISPR Gene Testing and Diagnostics Market Size 2017-2028
2.1.2 CRISPR Gene Testing and Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CRISPR Gene Testing and Diagnostics Segment by Type
2.2.1 Animals
2.2.2 Plants
2.2.3 Pathogens
2.2.4 Others
2.3 CRISPR Gene Testing and Diagnostics Market Size by Type
2.3.1 CRISPR Gene Testing and Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CRISPR Gene Testing and Diagnostics Market Size Market Share by Type (2017-2022)
2.4 CRISPR Gene Testing and Diagnostics Segment by Application
2.4.1 Medical Industry
2.4.2 Agriculture
2.4.3 Others
2.5 CRISPR Gene Testing and Diagnostics Market Size by Application
2.5.1 CRISPR Gene Testing and Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CRISPR Gene Testing and Diagnostics Market Size Market Share by Application (2017-2022)
3 CRISPR Gene Testing and Diagnostics Market Size by Player
3.1 CRISPR Gene Testing and Diagnostics Market Size Market Share by Players
3.1.1 Global CRISPR Gene Testing and Diagnostics Revenue by Players (2020-2022)
3.1.2 Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global CRISPR Gene Testing and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR Gene Testing and Diagnostics by Regions
4.1 CRISPR Gene Testing and Diagnostics Market Size by Regions (2017-2022)
4.2 Americas CRISPR Gene Testing and Diagnostics Market Size Growth (2017-2022)
4.3 APAC CRISPR Gene Testing and Diagnostics Market Size Growth (2017-2022)
4.4 Europe CRISPR Gene Testing and Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size Growth (2017-2022)
5 Americas
5.1 Americas CRISPR Gene Testing and Diagnostics Market Size by Country (2017-2022)
5.2 Americas CRISPR Gene Testing and Diagnostics Market Size by Type (2017-2022)
5.3 Americas CRISPR Gene Testing and Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR Gene Testing and Diagnostics Market Size by Region (2017-2022)
6.2 APAC CRISPR Gene Testing and Diagnostics Market Size by Type (2017-2022)
6.3 APAC CRISPR Gene Testing and Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CRISPR Gene Testing and Diagnostics by Country (2017-2022)
7.2 Europe CRISPR Gene Testing and Diagnostics Market Size by Type (2017-2022)
7.3 Europe CRISPR Gene Testing and Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CRISPR Gene Testing and Diagnostics by Region (2017-2022)
8.2 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CRISPR Gene Testing and Diagnostics Market Forecast
10.1 Global CRISPR Gene Testing and Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global CRISPR Gene Testing and Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas CRISPR Gene Testing and Diagnostics Forecast
10.1.3 APAC CRISPR Gene Testing and Diagnostics Forecast
10.1.4 Europe CRISPR Gene Testing and Diagnostics Forecast
10.1.5 Middle East & Africa CRISPR Gene Testing and Diagnostics Forecast
10.2 Americas CRISPR Gene Testing and Diagnostics Forecast by Country (2023-2028)
10.2.1 United States CRISPR Gene Testing and Diagnostics Market Forecast
10.2.2 Canada CRISPR Gene Testing and Diagnostics Market Forecast
10.2.3 Mexico CRISPR Gene Testing and Diagnostics Market Forecast
10.2.4 Brazil CRISPR Gene Testing and Diagnostics Market Forecast
10.3 APAC CRISPR Gene Testing and Diagnostics Forecast by Region (2023-2028)
10.3.1 China CRISPR Gene Testing and Diagnostics Market Forecast
10.3.2 Japan CRISPR Gene Testing and Diagnostics Market Forecast
10.3.3 Korea CRISPR Gene Testing and Diagnostics Market Forecast
10.3.4 Southeast Asia CRISPR Gene Testing and Diagnostics Market Forecast
10.3.5 India CRISPR Gene Testing and Diagnostics Market Forecast
10.3.6 Australia CRISPR Gene Testing and Diagnostics Market Forecast
10.4 Europe CRISPR Gene Testing and Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany CRISPR Gene Testing and Diagnostics Market Forecast
10.4.2 France CRISPR Gene Testing and Diagnostics Market Forecast
10.4.3 UK CRISPR Gene Testing and Diagnostics Market Forecast
10.4.4 Italy CRISPR Gene Testing and Diagnostics Market Forecast
10.4.5 Russia CRISPR Gene Testing and Diagnostics Market Forecast
10.5 Middle East & Africa CRISPR Gene Testing and Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt CRISPR Gene Testing and Diagnostics Market Forecast
10.5.2 South Africa CRISPR Gene Testing and Diagnostics Market Forecast
10.5.3 Israel CRISPR Gene Testing and Diagnostics Market Forecast
10.5.4 Turkey CRISPR Gene Testing and Diagnostics Market Forecast
10.5.5 GCC Countries CRISPR Gene Testing and Diagnostics Market Forecast
10.6 Global CRISPR Gene Testing and Diagnostics Forecast by Type (2023-2028)
10.7 Global CRISPR Gene Testing and Diagnostics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 10x Genomics
11.1.1 10x Genomics Company Information
11.1.2 10x Genomics CRISPR Gene Testing and Diagnostics Product Offered
11.1.3 10x Genomics CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 10x Genomics Main Business Overview
11.1.5 10x Genomics Latest Developments
11.2 Aelian Biotechnology
11.2.1 Aelian Biotechnology Company Information
11.2.2 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Product Offered
11.2.3 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Aelian Biotechnology Main Business Overview
11.2.5 Aelian Biotechnology Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies CRISPR Gene Testing and Diagnostics Product Offered
11.3.3 Agilent Technologies CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 Axxam
11.4.1 Axxam Company Information
11.4.2 Axxam CRISPR Gene Testing and Diagnostics Product Offered
11.4.3 Axxam CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Axxam Main Business Overview
11.4.5 Axxam Latest Developments
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Information
11.5.2 Beckman Coulter CRISPR Gene Testing and Diagnostics Product Offered
11.5.3 Beckman Coulter CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Beckman Coulter Main Business Overview
11.5.5 Beckman Coulter Latest Developments
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Information
11.6.2 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Product Offered
11.6.3 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Becton, Dickinson and Company Main Business Overview
11.6.5 Becton, Dickinson and Company Latest Developments
11.7 Binx Health
11.7.1 Binx Health Company Information
11.7.2 Binx Health CRISPR Gene Testing and Diagnostics Product Offered
11.7.3 Binx Health CRISPR Gene Testing and Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Binx Health Main Business Overview
11.7.5 Binx Health Latest Developments
11.8 bioM
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)